Biomind Labs Inc
NEO:BMND
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biomind Labs Inc
NEO:BMND
|
CA |
|
W
|
Welbilt Inc
F:6M6
|
US |
|
E
|
Everbright Jiabao Co Ltd
SSE:600622
|
CN |
|
H
|
High Sierra Technologies Inc
OTC:HSTI
|
US |
|
I
|
Inyx Inc
OTC:IYXI
|
US |
|
Skkynet Cloud Systems Inc
OTC:SKKY
|
CA |
Income Statement
Earnings Waterfall
Biomind Labs Inc
Income Statement
Biomind Labs Inc
| Sep-2018 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
1
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(5)
|
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Selling, General & Administrative |
(5)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Research & Development |
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
|
| Depreciation & Amortization |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(4)
N/A
|
(1)
+79%
|
(2)
-116%
|
(3)
-75%
|
(3)
+11%
|
(2)
+16%
|
(1)
+35%
|
(1)
+30%
|
(1)
+30%
|
(0)
+36%
|
(0)
+40%
|
(0)
-1%
|
(0)
N/A
|
(0)
+6%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(4)
N/A
|
(1)
+77%
|
(2)
-113%
|
(3)
-71%
|
(3)
+9%
|
(2)
+17%
|
(1)
+35%
|
(1)
+18%
|
(1)
+21%
|
(1)
+16%
|
(1)
+11%
|
(0)
+63%
|
(0)
+46%
|
(0)
+68%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(4)
|
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(5)
N/A
|
(1)
+84%
|
(2)
-113%
|
(3)
-71%
|
(3)
+9%
|
(2)
+17%
|
(1)
+35%
|
(1)
+18%
|
(1)
+21%
|
(1)
+16%
|
(1)
+11%
|
(0)
+63%
|
(0)
+46%
|
(0)
+68%
|
|
| EPS (Diluted) |
-0.02
N/A
|
-0.01
+50%
|
-0.02
-100%
|
-0.04
-100%
|
-0.04
N/A
|
-0.03
+25%
|
-0.02
+33%
|
-0.02
N/A
|
-0.01
+50%
|
-0.01
N/A
|
-0.01
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|